MYX 0.00% $3.88 mayne pharma group limited

Mithra’s Donesta phase 3 trial results, page-3

  1. 12,679 Posts.
    lightbulb Created with Sketch. 1333
    The US menopause market is massive and if affected women can be given another option then that is great. Let's hope of continued success for Donesta and that Mithra and Mayne Pharma can do another deal and build on the significant marketing and distribution capability already established for Nextstellis.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$3.88
Change
0.000(0.00%)
Mkt cap ! $330.0M
Open High Low Value Volume
$3.89 $3.94 $3.87 $178.6K 45.81K

Buyers (Bids)

No. Vol. Price($)
1 587 $3.88
 

Sellers (Offers)

Price($) Vol. No.
$3.90 137 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.